newsfilter
← Latest News
GlobeNewswire·

ProMIS Neurosciences initiates commercialization of COVID-19 serology assay

TORONTO and CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX:PMN); (OTCQB:ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicat